Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04798651 (ClinicalTrials.gov)	September 30, 2021	11/3/2021	Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis	Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis	Multiple Sclerosis;Clinically Isolated Syndrome	Biological: blood sample;Biological: cerebro-spinal fluid	University Hospital, Bordeaux	University of Bordeaux	Recruiting	18 Years	N/A	All	150	N/A	France
2	NCT03983720 (ClinicalTrials.gov)	January 21, 2020	7/6/2019	Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?	Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?	Sclerosis, Multiple	Other: Evaluation of degree chronic fatigue.;Other: Questionnaires;Biological: Blood sample;Other: Cardiopulmonary evaluation;Device: Capacity of muscular oxygen extraction;Device: Sleep assessment;Device: Metabolic fatigue;Other: Neuromuscular evaluation	Centre Hospitalier Universitaire de Saint Etienne	NULL	Recruiting	18 Years	70 Years	All	60	Phase 2	France
3	NCT02142764 (ClinicalTrials.gov)	November 2014	15/5/2014	Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients	Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (MS).	Multiple Sclerosis	Biological: Blood samples	University Hospital, Bordeaux	Merck Serono International SA;ADERA	Completed	18 Years	N/A	Both	30	N/A	France